![Kathleen Tregoning](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathleen Tregoning
Direktor/Vorstandsmitglied bei
SPERO THERAPEUTICS, INC.
Vermögen: 155 650 $ am 31.05.2026
Profil
Kathleen Tregoning is an Independent Director at Spero Therapeutics, Inc. since 2021 and an Independent Director at Compass Pathways Plc starting in 2026.
Formerly, Ms. Tregoning was a Member of the United States Congress, Executive Vice President-External Affairs at Sanofi from 2017 to 2020, Chief Corporate Affairs Officer at Cerevel Therapeutics Holdings, Inc. from 2020 to 2024, and Senior Vice President-Corporate Affairs at Biogen, Inc. from 2015 to 2017.
Education includes undergraduate studies at Stanford University and graduate studies at Harvard Kennedy School of Government.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SPERO THERAPEUTICS, INC. 0,09 % | 01.04.2026 | 55.000 ( 0,09 % ) | 155 650 $ | 31.05.2026 |
COMPASS PATHWAYS PLC -.--% | 27.05.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Kathleen Tregoning
| Unternehmen | Position | Beginn |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 11.10.2021 |
| COMPASS PATHWAYS PLC | Direktor/Vorstandsmitglied | 06.04.2026 |
Ehemalige bekannte Positionen von Kathleen Tregoning
| Unternehmen | Position | Ende |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | 01.08.2024 |
| SANOFI | Public Communications Contact | 01.03.2020 |
| BIOGEN INC. | General Counsel | 01.12.2015 |
United States Congress | Corporate Officer/Principal | - |
Ausbildung von Kathleen Tregoning
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
78
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Harvard Kennedy School of Government
 Harvard Kennedy School of Government Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Compass Pathways Plc
 Compass Pathways Plc BiotechnologyHealth Technology Develops therapies and drugs for the treatment of mental health and neurocognitive conditions | Health Technology |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
United States Congress |
